Compare dividend stocks

ABBV vs MRK

AbbVie Inc. provides a 2.72% dividend yield, marginally above Merck & Company, Inc.'s 2.67%. Merck boasts a 14-year dividend streak and slightly better 3-year and 5-year CAGRs, though AbbVie leads in trailing twelve-month growth. In terms of safety and valuation, Merck is rated "watch" and "fair" by yield theory, unlike AbbVie which is "at_risk" and "overvalued."

ABBV AB
ABBV
MRK MR
MRK

Key differences

Yield

ABBV AB
ABBV

2.72%

MRK 2.67%

CAGR 5y

MRK MR
MRK

+6.8%

ABBV +6.8%

Safety

MRK MR
MRK

Watch

ABBV At risk

Dividend score

ABBV 3/10

MRK 3/10

ABBV AB
ABBV Yield Growth Momentum Safety Value Health
3 · Weak At risk
MRK MR
MRK Yield Growth Momentum Safety Value Health
3 · Weak Watch

Price

254.5 USD 127.5 USD

Today

+0.0% -0.1%

Dividend/share

6.9 USD 3.4 USD

2.72% 2.67%

Growth (TTM)

+5.6% +5.0%

CAGR 3y

+5.2% +5.5%

+6.8% +6.8%

12y 14y

Dividend status

Contender (10y+) Contender (10y+)

10.6y 10.5y

Dividend score

3/10 3/10

Safety

At risk Watch
Unlock the full valuation comparison

Chowder number, fair value and Dividend Yield Theory for every stock — plus track them in your portfolio.

The information on Quantic is provided for informational and educational purposes only. It is general in nature, does not take into account your personal financial situation, and does not constitute investment, financial, tax, or legal advice — nor a recommendation to buy or sell any security. Investing involves risk, including possible loss of principal; past performance is not a reliable indicator of future results. Market data comes from third-party providers and may be delayed or inaccurate. Before making any investment decision, consider your objectives, time horizon, risk tolerance, and diversification, and consult a qualified financial professional. Quantic is not a registered investment adviser or broker-dealer.

Built with Elixir, Phoenix LiveView, and Tailwind CSS

© 2026 Francesc Leveque